2008 annual financial data
Corcept Therapeutics 2008 Operating cash flow margin
Direct answer
Operating cash flow margin was -8,785.65%.
Operating income was -19,689,000 USD and net income was -20,061,000 USD.
Operating cash flow was -18,362,000 USD.
Get free Corcept Therapeutics email updates.
Bullstory sends one daily email when new analysis or important company news is available.
Verified data
- Revenue
- 209,000 USD
- Operating income
- -19,689,000 USD
- Net income
- -20,061,000 USD
- Operating cash flow
- -18,362,000 USD